A clinical trial to compare the effects of two methods of obtaining hair stem cells for treating vitiligo
Phase 2
Completed
- Conditions
- Health Condition 1: null- Segmental/generalised, stable vitiligo
- Registration Number
- CTRI/2016/08/007133
- Lead Sponsor
- one
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Segmental or generalised vitiligo
2. Stable for at least 1.5 years
3. One large patch of size at least 18 cm2
OR minimum 3 patches of at least 9cm2 each
Exclusion Criteria
1. Age less than 18 years
2. Pregnancy
3. Koebnerization
4. Keloid or bleeding diathesis
5. Active infection at site
6. Other autoimmune diseases
7. Inability to follow up for at least 6 months
8. Acral sites & bony prominences as recipient sites
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percentage repigmentation achieved in the recipient sites of transplantationTimepoint: 6 months post surgery
- Secondary Outcome Measures
Name Time Method Percentage repigmentation achieved in the recipient sites of transplantationTimepoint: 1 week, 1 month, 2 months and 3 months post surgery